Alterity Therapeutics ATHE
NASDAQ ATHE
$2.31 -0.01 (-0.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Alterity Therapeutics (ATHE) Short-term Investments (2019 - 2025)

Updated

Alterity Therapeutics (ATHE) posted Short-term Investments of $21.78 million for the quarter ended Jun 30, 2026, up 103.3% from $10.71 million a year earlier.

Analysis

Alterity Therapeutics (ATHE) Short-term Investments (2019 - 2025) Analysis & Trends

Since the quarter ended Jun 30, 2021, Alterity Therapeutics has reported Short-term Investments for 6 quarters.

  • Annual Short-term Investments shows a five-year compound annual growth rate of 54.7% (years ended Jun 2021 to Jun 2026).
  • In prior years, Alterity Therapeutics' Short-term Investments was $10.71 million in the year ended Jun 30, 2025, $17,002 in the year ended Jun 30, 2024 (-86.8%), $128,802 in the year ended Jun 30, 2023 (-6.7%) and $138,034 in the year ended Jun 30, 2022 (-94.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Alterity Therapeutics 42.05 Mn -41.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 27,318.64
Jun 30, 2024 27,046.66
Jun 30, 2023 26,322.62
Jun 30, 2022 7,040.09
Jun 30, 2020 6.76 Mn
Jun 30, 2019 13.91 Mn
API Access

Alterity Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ATHE&period=max&api_key=YOUR_API_KEY